Cannabis Users Reacted More Strongly to Stress but Also Recovered Faster Than Non-Users

In a 4-week trial with 499 anxious participants, all three cannabis product types (THC-dominant, CBD-dominant, 1:1) produced both greater emotional reactivity to stress and stronger recovery compared to non-use.

Skrzynski, Carillon J et al.·Journal of psychopathology and clinical science·2025·Moderate Evidenceclinical-trial
RTHC-07676Clinical TrialModerate Evidence2025RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
clinical-trial
Evidence
Moderate Evidence
Sample
N=152

What This Study Found

All three cannabis conditions (THC-dominant, CBD-dominant, 1:1 ratio) showed greater emotional reactivity to a rumination task but also stronger recovery after a breathing exercise compared to the non-use condition. THC products elevated heart rate compared to CBD and non-use. CBD did not change heart rate relative to non-use. Effects were observed after 4 weeks of ad libitum use.

Key Numbers

499 participants with mild+ anxiety. 4 weeks ad libitum use. THC-dominant (n=152), CBD-dominant (n=163), 1:1 (n=140), no use (n=44). All cannabis conditions: greater reactivity and recovery vs. non-use. THC elevated HR vs. CBD and non-use. CBD did not change HR vs. non-use.

How They Did This

Experimental study with 499 individuals with at least mild anxiety (66% female, 68% White) assigned to 4 weeks of ad libitum use of THC-dominant (n=152), CBD-dominant (n=163), 1:1 ratio (n=140), or no product (n=44). Baseline and post-use sessions measured affect and heart rate before and after a rumination task and breathing recovery exercise. Three-level mixed effect models analyzed outcomes.

Why This Research Matters

This is one of the few extended-use experimental studies comparing different cannabinoid profiles for anxiety. The finding that cannabis increases both reactivity and recovery complicates simple claims about cannabis either helping or harming anxiety.

The Bigger Picture

The dual finding of greater reactivity and recovery suggests cannabis may intensify emotional processing rather than simply dampening or amplifying it. This has implications for how cannabis is used in anxiety management and could explain mixed results in other studies.

What This Study Doesn't Tell Us

Non-randomized product assignment (ad libitum use). Very small non-use control group (n=44). Products were not standardized pharmaceutical preparations. No blinding. Self-selected anxious population. 4-week window may not capture longer-term effects.

Questions This Raises

  • ?Does cannabis enhance emotional processing in a way that could be therapeutically useful?
  • ?Would the reactivity-recovery pattern look different with standardized doses?

Trust & Context

Key Stat:
Evidence Grade:
Experimental design with adequate sample and extended use period, but non-randomized assignment, small control group, and ad libitum dosing limit to moderate.
Study Age:
Recently published experimental study.
Original Title:
Experimental study on cannabis use and affect: Effects on reactivity to and recovery from negative stimuli.
Published In:
Journal of psychopathology and clinical science, 134(6), 639-650 (2025)
Database ID:
RTHC-07676

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Frequently Asked Questions

Does cannabis help or hurt anxiety?

This study suggests it does both. All cannabis types made participants react more strongly to a stressor but also recover more completely. The net effect on anxiety may depend on the individual and situation.

Is CBD better than THC for anxiety?

Both produced similar patterns of greater reactivity and recovery. The key difference was that THC elevated heart rate while CBD did not, which matters for people whose anxiety involves physiological symptoms.

Read More on RethinkTHC

Cite This Study

RTHC-07676·https://rethinkthc.com/research/RTHC-07676

APA

Skrzynski, Carillon J; Rosa, Luiza; Drake, Austin; Bryan, Angela D; Bidwell, L Cinnamon. (2025). Experimental study on cannabis use and affect: Effects on reactivity to and recovery from negative stimuli.. Journal of psychopathology and clinical science, 134(6), 639-650. https://doi.org/10.1037/abn0001023

MLA

Skrzynski, Carillon J, et al. "Experimental study on cannabis use and affect: Effects on reactivity to and recovery from negative stimuli.." Journal of psychopathology and clinical science, 2025. https://doi.org/10.1037/abn0001023

RethinkTHC

RethinkTHC Research Database. "Experimental study on cannabis use and affect: Effects on re..." RTHC-07676. Retrieved from https://rethinkthc.com/research/skrzynski-2025-experimental-study-on-cannabis

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.